Unusual volume scanner: high RVOL stocks today
Volume precedes price. Before a stock breaks out, before the news wire prints, before the chat-room alert fires, volume is moving. Relative volume is the metric that surfaces it.
Leader right now: IMRN +56.38% at $1.75. Sourced from the live 15-min-delayed scanner snapshot above.
// As of September 4, 2026 · delayed 15 min
What's moving the tape on IMRN, grounded in Tapeboard's data. Not investment advice.
As of
- Headline: “Immuron to launch PROIBS® in the United States” (Yahoo) drove the surge. - Headline: “Immuron Stock Surges Friday: What's Driving the Action?” (Benzinga) notes the exclusive U.S. distribution deal as the catalyst.
- RVOL of 2,395× shows extraordinary retail interest accompanying the PROIBS® launch news. - Days to cover at 1.7 days and low short interest suggest limited downside pressure from shorts.
- EPS is negative (‑0.59) and P/E is ‑3.6, indicating no current profitability. - Market cap is only ~$14.5 M, making the stock highly susceptible to volatility and dilution.
- easyToBorrow is false, potentially limiting short‑sale ability and increasing borrowing costs. - Squeeze score is just 7.8/100, implying little short‑squeeze potential despite low days to cover.
- Actual U.S. sales trajectory and adoption rate for PROIBS® remain unspecified. - Future dilution from any needed financing to support the launch is not disclosed. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on CDTG, grounded in Tapeboard's data. Not investment advice.
As of
- No recent news available in the data - Price up 70.09% to $1.53 on 43.8 M shares traded vs. average low volume
- Extremely low price-to-book (0.027) and price-to-sales (0.045) suggest deep value - Short interest is minimal (0.16 days to cover, squeeze score 8/100) limiting downside pressure
- EPS is deeply negative at –$20.99, indicating ongoing losses - Market cap is only ~$4.6 M with a float of ~2.8 M shares, making the stock highly illiquid and volatile
- Easy-to-borrow flag is false, indicating potential borrowing constraints for shorts - 52‑week range shows the price is just 2% above the low, suggesting limited upside room
- No analyst estimates or earnings surprises are provided to gauge future performance - Absence of recent news leaves unclear what catalyst, if any, is driving the spike --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on AMC, grounded in Tapeboard's data. Not investment advice.
As of
- Robinhood's Offshore AMC Token Setup Is 'Shocking and Shameful,' AMC CEO Says (Benzinga) - AMC Stock Pops on Robinhood Feud, But 892 Million Shares Is the Real Dilution Story (Benzinga)
- Q2 2026 earnings beat estimate by $0.13, +214.9% surprise - Analyst consensus shows 2 strong buys, 4 buys, 5 holds across periods
- FY 2025 net income -$0.63B, EPS -1.34, negative book value per share - Operating cash flow negative -$119.8M FY 2025, free cash flow -$365.9M
- Squeeze score only 10/100, days to cover ~1.0, low short‑interest pressure - Total stockholders equity -$1.89B, net debt $3.61B, high leverage
- Outcome of AMC’s legal challenge against Robinhood token setup - Future impact of ongoing share dilution on valuation and trading dynamics --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on GPRO, grounded in Tapeboard's data. Not investment advice.
As of
- GoPro announced a $285 million all‑cash merger with Starman Optical, valuing shares at $1.14 each (≈29.5% premium). - Retail attention spiked after YouTuber Markiplier became the largest shareholder, driving a 40% rally and unusually high volume (RVOL 4.12×).
- The merger adds AI‑data‑center and defense exposure, potentially diversifying revenue beyond action cameras. - Elevated trading volume and retail interest suggest short‑term momentum could sustain price gains.
- FY‑2025 fundamentals show revenue down 18.7% YoY, net loss of $93 M, and negative EPS (‑$0.59). - Gross margin remains modest at 33.6% and operating cash flow is negative (‑$20.7 M).
- Short interest is low (≈24.9 M shares, days‑to‑cover 4.5) and squeeze score is weak (13.2/100), limiting short‑squeeze upside. - The stock remains well below its 52‑week high ($3.05) and trades at a deep discount to book value (‑$0.18/share).
- How quickly Starman Optical’s AI/defense initiatives will generate revenue and affect GoPro’s top line. - Whether the retail‑driven volume surge will persist once merger‑related news cycles fade. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on ALAB, grounded in Tapeboard's data. Not investment advice.
As of
- Astera Labs shares rose 10.8% on hopes of being added to the S&P 500 during Friday’s rebalancing (Bloom Energy, Astera Rally On Hopes They Will Join S&P Friday). - The stock also benefited from broad Friday momentum in AI‑related names and a strong earnings surprise in Q2 2026 (actual EPS $0.80 vs estimate $0.705).
- Analyst consensus remains heavily bullish with 7 strong‑buy and 14 buy ratings across recent periods. - Revenue surged 115% YoY to $0.85B in FY 2025, gross margin 75.7%, and free cash flow exceeded $281M.
- Valuation multiples are extreme: P/E 154×, P/B 31.5×, P/S 45.2×, suggesting price may be detached from fundamentals. - Short interest is modest (8.75M shares, ~1.9 days to cover) and the squeeze score is low (11.6/100), limiting short‑covering upside.
- High reliance on speculative S&P inclusion news; any disappointment could trigger a sharp reversal. - Elevated multiples leave little margin for error if growth slows or macro conditions tighten.
- Whether Astera Labs will actually be added to the S&P 500 and the timing of any announcement. - Sustainability of the 115% revenue growth rate beyond FY 2025 and future profitability trends. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
See this live in the Tapeboard scanner
This table is baked at build time and never moves. The scanner runs the same scan continuously, streaming and filterable, with a chart and research pane one click away on every row. Free, no account needed.
Open the live unusual-volume scannerWhat are the biggest unusual-volume movers today?
- // RVOL above 2x the 10-day average for the same time of day
- // Sorted by RVOL descending so the biggest anomalies surface first
- // Optional price floor to exclude illiquid sub-$1 names
- // Optional gap and float filters layered on top
- // Click-through to time and sales, Level 2 book, and recent filings
- // Streaming real-time. Rows update as prints land, not on a 10-second refresh delay.
- // Click any ticker for the full research pane: chart, Level 2, time & sales, filings, insider activity, news recency.
- // 15-minute delay on the public surface; signed-in users see the live tape without delay.
- // Free to view. No card. No paywall on this page.
// Other movers categories you might want next to this one:
Watch the movers live on Tapeboard.
// 28 sec to first scanner · no card · cancel anytime
Start free View pricing See it live in the scanner